Onconova Logo BLUE.jpg
Onconova Therapeutics Reports Second Quarter 2022 Financial Results and Provides Business Update
August 11, 2022 16:05 ET | Onconova Therapeutics, Inc.
NEWTOWN, Pa., Aug. 11, 2022 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX), (“Onconova”), a clinical-stage biopharmaceutical company focused on discovering and developing novel...
Cancer Support Commu
Cancer Support Community and Carevive Partner on Innovative Care Delivery Model
August 11, 2022 13:00 ET | Cancer Support Community
WASHINGTON, D.C., Aug. 11, 2022 (GLOBE NEWSWIRE) -- The Cancer Support Community (CSC) and Carevive are partnering to provide an innovative nursing and social work team-based care delivery model to...
MNPR Triangle 2.JPG
Monopar Therapeutics Reports Second Quarter 2022 Financial Results and Recent Program Developments
August 11, 2022 08:05 ET | Monopar Therapeutics Inc.
WILMETTE, Ill., Aug. 11, 2022 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (Monopar or the Company) (Nasdaq: MNPR), a clinical-stage biopharmaceutical company focused on developing proprietary...
Summit-logo-RGB.png
Summit Therapeutics Inc Reports Financial Results and Operational Progress for the Second Quarter Ended June 30, 2022
August 11, 2022 08:00 ET | Summit Therapeutics Inc.
Menlo Park, California, Aug. 11, 2022 (GLOBE NEWSWIRE) -- Summit Therapeutics Inc. (NASDAQ: SMMT) ("Summit," "we," or the "Company") today reports its financial results and provides an update on...
shattuck-logo-dark-h.png
Shattuck Labs Reports Second Quarter 2022 Financial Results and Recent Business Highlights
August 11, 2022 07:00 ET | Shattuck Labs, Inc.
– Enrollment of Phase 1B clinical trial of SL-172154 in combination with liposomal doxorubicin in platinum-resistant ovarian cancer expected to begin in Q3’2022 with initial combination data expected...
new_logo.png
Imaging Agents Market Trends 2022 | North America, Europe, & APAC Industry Forecasts 2028: Graphical Research
August 10, 2022 08:00 ET | Graphical Research
Pune, India, Aug. 10, 2022 (GLOBE NEWSWIRE) -- The global imaging agents market size is estimated to increase exponentially during the forecast period, attributed to rising demand for innovative...
RevolutionLogo.png
Revolution Medicines Reports Second Quarter 2022 Financial Results and Update on Corporate Progress
August 09, 2022 16:02 ET | Revolution Medicines, Inc.
First two RAS(ON) Inhibitor drug candidates advance into clinical development Successful equity financing supports development of portfolio of targeted drug candidates for RAS-addicted cancers ...
Summit-logo-RGB.png
Summit Therapeutics Closes Fully-Subscribed $100 Million Rights Offering
August 09, 2022 13:37 ET | Summit Therapeutics Inc.
Menlo Park, California, Aug. 09, 2022 (GLOBE NEWSWIRE) -- Summit Therapeutics Inc. (NASDAQ: SMMT) (“Summit,” "we," or the “Company”) today announced the successful closing of its fully-subscribed...
Predicine.png
Predicine Expands to Europe with the recently launched CE-Marked cfDNA Assay PredicineCARE™ for Genomic Profiling in Blood and Urine
August 09, 2022 08:00 ET | Predicine
SILICON VALLEY, Calif., Aug. 09, 2022 (GLOBE NEWSWIRE) -- Predicine, Inc., a global molecular insights company, has launched its CE-marked PredicineCARE™ for genomic profiling in blood and urine....
PDS Biotech Logo.png
PDS Biotech Reports Second Quarter 2022 Financial Results and Provides Business Update
August 08, 2022 07:00 ET | PDS Biotechnology Corporation
Announced results from two of the ongoing Phase 2 clinical trials of PDS0101 in multiple, difficult-to-treat HPV16-related cancers presented at the American Society of Clinical Oncology...